TAMSUNORM COMBI

Modified-release tablet, 0.4mg + 6mg
RxActive license

Active substance (INN)

solifenacintamsulosin

Pharmaceutical form

Pharmaceutical formModified-release tablet
Strength0.4mg + 6mg
PackagingUkupno 30 tableta sa modifikovanim oslobađanjem u blisteru (2x15) u kartonskoj kutiji
ManufacturerAdamed Pharma S.A., Poland
Therapeutic groupGenito-urinary system and sex hormones (G04CA53)
Marketing authorization holderPHARMASWISS - MONTENEGRO, PHARMASWISS DOO BEOGRAD, DIO STRANOG DRUŠTVA U PODGORICI
Authorization dateAugust 11, 2023

Analogs in Montenegro

10

Other medicines with the same active substance

BETAMSALRx
Modified-release capsule, hard, 0.4mgHemofarm a.d. Vršac
DUTAMERARx
Capsule, hard, 0.4mg + 0.5mgLaboratorios Leon Farma S.A.
FLOSINRx
Modified-release capsule, hard, 0.4mgMenarini - Von Heyden GmbH
SAURUS COMBORx
Modified-release tablet, 0.4mg + 6mgStada Arzneimittel AG
TAMLOSRx
Modified-release capsule, hard, 0.4mgAlkaloid AD Skopje
TAMLOS® DUODRx
Capsule, hard, 0.5mg + 0.4mgAlkaloid AD Skopje
TAMPROST®Rx
Prolonged-release tablet, 0.4mgLek farmacevtska družba d.d. (Lek Pharmaceuticals d.d.)
TAMSOLRx
Prolonged-release capsule, hard, 0.4mgPharmaswiss d.o.o.
TAMSULOSIN HFRx
Modified-release capsule, hard, 0.4mgStada Arzneimittel AG
VERION DUORx
Capsule, hard, 0.5mg/0.4mgBosnalijek d.d.
Source: CInMED register